Stock Report

Download full stock data and analysis for free Last Updated: 03-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

ESSA Pharma - ADR Key Ratios

Stock Card factsheet share-fund-plan-icon

$0.20

up-down-arrow $0.00 (-0.10%)

As on 09-Oct-2025 09:30EDT

Market cap

info icon

$10 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.1

Div. Yield

info icon

87.6 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -- -- --
EBIT 21.63 30.93 0.09 8.02 -10.10
Net Profit 37.20 44.66 8.69 9.75 -6.07
EPS 37.20 44.69 9.01 10.21 7.22
Book Value -- -- -14.95 -15.95 -3.48
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMSep-24Sep-23
EBIT-Margin info -----20,363.00----
Net Margin info -----18,611.02----
Return on equity info -19.19-24.20-22.19-21.12-17.00
Return on Capital info -19.16-23.97---21.09-16.98
Return on Assets info -18.79-23.48-20.35-20.59-16.69
Debt to Equity (x) info ----0.000.000.00

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
--
-21.09
-16.98
-19.41
-26.90
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-22.19

Lower than Peers by 6.22

Profit after tax / Average Net worth * 100

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
-22.19
-21.12
-17.00
-19.44
-26.94
Peer Median
-15.98
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-20.35

Lower than Peers by 8.50

Profit after tax / Average Total assets * 100

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
-20.35
-20.59
-16.69
-19.09
-26.41
Peer Median
-11.85
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-20,363.00

Lower than Peers by 20,335.95

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
-20,363.00
--
--
--
--
Peer Median
-27.06
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-18,611.02

Lower than Peers by 18,578.34

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
-18,611.02
--
--
--
--
Peer Median
-32.69
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

-0.21

Lower than Peers by 0.21

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
-0.21
--
--
--
--
Peer Median
0.00
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

--

--

Year on year growth in net sales

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
--
--
--
--
--
Peer Median
33.97
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

0.09

Higher than Peers by 25.34

Year on year growth in operating profit (EBIT)

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
0.09
-7.41
24.51
4.39
-59.27
Peer Median
-25.26
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

8.69

Higher than Peers by 30.26

Year on year growth in profit after tax

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
8.69
-7.38
24.27
4.63
-56.99
Peer Median
-21.58
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

9.01

Higher than Peers by 15.18

Year on year growth in earnings per share

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
9.01
-0.07
0.24
0.11
-0.05
Peer Median
-6.17
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

-15.53

Lower than Peers by 12.64

Year on year growth in book value per share

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
-15.53
--
--
--
--
Peer Median
-2.89
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
--
0.00
0.00
0.00
0.00
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
--
0.00
0.00
0.00
0.00
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

69.07

Higher than Peers by 59.96

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
69.07
38.64
42.57
73.38
50.28
Peer Median
9.11
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

69.07

Higher than Peers by 59.96

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
69.07
--
--
25.50
--
Peer Median
9.11
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
--
--
-3,827.97
-2,514.38
-1,656.96
Peer Median
0.72
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

388.31

Higher than Peers by 365.56

Debtors outstanding / Net Sales * 100

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
388.31
--
--
--
--
Peer Median
22.75
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.00

Lower than Peers by 0.06

Sales / Average Total Assets

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
0.00
--
--
--
--
Peer Median
0.06
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
--
--
340,947.97
331,720.68
-1,032.84
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
--
8,925.29
4,597.36
3,569.62
3,511.08
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
--
-9.42
-5.13
-2.29
-8.92
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

0.09

Lower than Peers by 4.73

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
0.09
2.16
0.94
0.48
1.69
Peer Median
4.83
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

87.56

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
87.56
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-8.09

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
-8.09
-5.01
0.44
2.47
-3.64
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

10

Lower than Peers by 207

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Sep-24
Sep-23
Sep-22
Sep-21
ESSA Pharma - ADR
10
--
--
--
--
Peer Median
217
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...